In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Wy-21,743 Drug Master File in Korea (Wy-21,743 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Wy-21,743. The MFDS reviews the Wy-21,743 KDMF as part of the drug registration process and uses the information provided in the Wy-21,743 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Wy-21,743 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Wy-21,743 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Wy-21,743 suppliers with KDMF on PharmaCompass.